908 DevicesMASS
MASS logo
Fair Value
US$12
Share price12 Aug
US$7.1140.8% undervalued intrinsic discount
Loading
1Y-3.66%
7D-4.05%

Decentralized Diagnostics And Global Security Will Expand Analytical Markets

Analyst High Target compiles bullish analysts opinions to create narratives which represent one standard deviation above the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls

Published
12 Aug 25
Views
7
Not Invested

Fair Value vs Share Price

US$12
vs US$7.1140.8% undervalued intrinsic discount
PastFuture-50m81m2018202020222024202520262028Revenue US$81.0mEarnings US$7.3m
7.3%
Revenue growth
9%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on 908 Devices

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Flawless balance sheet with very low risk.

Market capUS$297.0m
PB2.2x
Estimated Growth19.1%
Dividend YieldN/A
Full analysis

CEO & management

Kevin Knopp
CEO
3.5yrs
CEO Tenure

Provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications.